CANI, ALICE
 Distribuzione geografica
Continente #
NA - Nord America 499
EU - Europa 315
AS - Asia 188
SA - Sud America 17
AF - Africa 1
Totale 1.020
Nazione #
US - Stati Uniti d'America 497
PL - Polonia 190
SG - Singapore 88
CN - Cina 58
IT - Italia 38
UA - Ucraina 21
BR - Brasile 17
DE - Germania 14
FI - Finlandia 14
GB - Regno Unito 14
TR - Turchia 14
VN - Vietnam 8
ID - Indonesia 7
BE - Belgio 6
SE - Svezia 5
HK - Hong Kong 4
NO - Norvegia 3
PK - Pakistan 3
CA - Canada 2
HU - Ungheria 2
IN - India 2
RO - Romania 2
AT - Austria 1
BG - Bulgaria 1
EG - Egitto 1
FR - Francia 1
IE - Irlanda 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
MD - Moldavia 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
Totale 1.020
Città #
Warsaw 190
Fairfield 62
Houston 50
Chandler 47
Woodbridge 45
Ann Arbor 39
Singapore 36
Santa Clara 33
Ashburn 32
Jacksonville 25
Seattle 24
Wilmington 21
Cambridge 18
Ferrara 13
Helsinki 10
Nanjing 9
Shanghai 9
Beijing 7
Boardman 7
Izmir 7
Jakarta 7
Princeton 7
Brussels 6
Dong Ket 6
Milan 5
Nanchang 5
Cagliari 4
Dearborn 4
London 4
Los Angeles 4
New York 4
Sant'elena 4
Hebei 3
Hong Kong 3
Shenyang 3
Addison 2
Bremen 2
Changsha 2
Focsani 2
Győr 2
Hanoi 2
Harringay 2
Jinan 2
Roncoferraro 2
São Paulo 2
Toronto 2
Trondheim 2
Yichang 2
Zhengzhou 2
Americana 1
Ankara 1
Belo Horizonte 1
Bhavnagar 1
Bishkek 1
Bologna 1
Brasília 1
Campo Grande 1
Campos dos Goytacazes 1
Cantagalo 1
Carangola 1
Cassilândia 1
Central District 1
Chengdu 1
Chisinau 1
Criciúma 1
Des Moines 1
Dublin 1
El Mahalla El Kubra 1
Faisalabad 1
Frankfurt am Main 1
Goiana 1
Hangzhou 1
Harbin 1
Itapema 1
Lahore 1
Lanzhou 1
Nantong 1
Newark 1
Norwalk 1
Nova Hartz 1
Nuremberg 1
Oslo 1
Pitanga 1
Potomac 1
Pune 1
Quzhou 1
Redmond 1
Redwood City 1
San Diego 1
St Petersburg 1
Suseong-gu 1
São Bernardo do Campo 1
Tappahannock 1
Tashkent 1
Taubaté 1
Tianjin 1
Varna 1
Wuhan 1
Xi'an 1
Xian 1
Totale 832
Nome #
Targeting the PI3K/Akt/mTOR signaling pathway as a new therapeutic strategy for personalized treatments in acute lymphoblastic leukemia 212
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 173
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 164
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 148
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential. 146
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 97
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation. 38
The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy 32
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 31
Totale 1.041
Categoria #
all - tutte 5.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 0 0 0 0 0 22 13 14
2020/2021194 14 21 10 13 17 18 14 17 10 37 13 10
2021/202275 1 16 10 0 4 5 3 3 3 6 9 15
2022/2023102 10 7 9 14 15 15 6 7 9 1 7 2
2023/202473 3 5 3 0 5 12 5 16 2 1 6 15
2024/2025192 6 7 16 9 40 25 13 7 68 1 0 0
Totale 1.041